欧洲胰岛素笔市场至 2027 年 - 按产品类型（一次性和可重复使用）进行区域分析和预测；应用（1 型糖尿病和 2 型糖尿病）；分销渠道（医院药房、零售药房和电子商务）和地理位置
No. of Pages: 120 | Report Code: TIPRE00006289 | Category: Life Sciences
No. of Pages: 120 | Report Code: TIPRE00006289 | Category: Life Sciences
老年人口增长和糖尿病发病率上升等因素推动了市场的增长。然而，由于该地区药物输送替代品的可用性以及与胰岛素笔相关的限制，市场可能会受到影响。
老年人群中的糖尿病是全球日益严重的公共卫生负担。它是老龄化人口发病和死亡的主要原因，后来主要归因于各种慢性并发症。人口老龄化将成为最重大的转变之一，对整个欧洲的社会和经济水平产生重大影响。根据联合国2017年的报告，2017年欧洲60岁及以上人口约为1.83亿，预计到2050年将达到2.472亿。欧洲老年人口数量预计将大幅增长，糖尿病已成为一个日益严重的健康问题，并给发展中国家的人口和卫生系统带来沉重负担。欧洲约有 6000 万糖尿病患者，即 25 岁及以上男性中约 10.3%，女性中约 9.6%。在欧洲地区，各年龄段的糖尿病患病率都在增加，主要原因是超重和肥胖、不健康饮食和缺乏身体活动的增加。老年人比年轻人更容易患糖尿病，而且这种疾病对这一人群生活质量的影响尤其深。随着老年人口数量的增加，糖尿病的患病率也随之增加。因此，胰岛素笔（一种方便注射胰岛素的装置）的需求预计在预测期内将会增加。
德国预计将引领市场欧洲地区由于糖尿病患病率上升以及该国政府的支持。此外，德国政府正在努力改善糖尿病患者的生活条件。因此，考虑到上述因素，在预测期内，该国市场的增长可能在欧洲地区贡献最大份额。
按地理位置
Strategic insights for Europe Insulin Pens involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 900.8 Million |
| Market Size by 2027 | US$ 1,829.7 Million |
| Global CAGR (2019 - 2027) | 8.4% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Insulin Pens refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The Europe Insulin Pens Market is valued at US$ 900.8 Million in 2018, it is projected to reach US$ 1,829.7 Million by 2027.
As per our report Europe Insulin Pens Market, the market size is valued at US$ 900.8 Million in 2018, projecting it to reach US$ 1,829.7 Million by 2027. This translates to a CAGR of approximately 8.4% during the forecast period.
The Europe Insulin Pens Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Insulin Pens Market report:
The Europe Insulin Pens Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Insulin Pens Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Insulin Pens Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Insulin Pens Market
